Search clinical trials for: Hormone Receptor (HR) Positive Breast Cancer
Total 148493 results
-
Washington University School of MedicineUnited States Department of Defense; Aclaris Therapeutics, Inc.Not yet recruitingHormone Receptor Positive HER-2 Negative Metastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Novartis PharmaceuticalsRecruitingBreast CancerUnited States
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingBone Diseases, Metabolic | Glomerular Disease | Bone FractureUnited States
-
Medical College of WisconsinNot yet recruiting
-
Theodoros FoukakisTerminatedBreast Cancer MetastaticSweden, United Kingdom
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
ETOP IBCSG Partners FoundationPfizerRecruitingBreast Cancer RecurrentSwitzerland, Italy, France, Spain, Hungary, Austria
-
BiogenCompletedBreast CancerUnited States, Russian Federation, Australia, Belgium
-
Genomic Health®, Inc.Registrat-MapiCompletedBreast CancerFrance
-
Tongji HospitalRecruiting
-
Gilead SciencesParexel; Iqvia Pty Ltd; Medidata SolutionsActive, not recruitingMetastatic Breast CancerKorea, Republic of, Taiwan, China
-
Mothaffar RimawiAstraZenecaCompletedBreast CancerUnited States
-
MedSIREli Lilly and CompanyActive, not recruitingBreast Cancer MetastaticItaly, Spain, Portugal
-
University Hospital, BordeauxRecruitingEpilepsy | Parkinson DiseaseFrance
-
Xuanzhu Biopharmaceutical Co., Ltd.Not yet recruitingAdvanced Breast CancerChina
-
University of Michigan Rogel Cancer CenterRecruiting
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruiting
-
Saint Luke's Health SystemNovartis PharmaceuticalsRecruitingMetastatic Breast Cancer | HER2-negative Breast CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTargeted Therapy | HR+/HER2- Advanced Breast CancerChina
-
Novartis PharmaceuticalsCompletedHR+/HER2- Advanced or Metastatic Breast CancerIreland
-
Hospices Civils de LyonUnknown
-
Nuvation Bio Inc.WithdrawnBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Cancer of Breast | Malignant Tumor of Breast | Breast Tumor | Cancer of the BreastUnited States
-
Georgetown UniversityUniversity of Chicago; Thomas Jefferson UniversityCompletedHormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...UnknownBreast Cancer | HER2-positive Breast CancerChina
-
University of Colorado, DenverCompletedHypotension | Kidney InjuryUnited States
-
Johns Hopkins UniversityCompletedHealth-Related Quality Of LifeUnited States
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Locally Advanced Malignant NeoplasmItaly
-
American Academy of PediatricsUniversity of North Carolina, Chapel Hill; Thrasher Research Fund; RTI International and other collaboratorsCompletedStillbirth | Neonatal Resuscitation | Neonatal Respiratory Depression | Neonatal BradycardiaCongo, The Democratic Republic of the
-
Mayo ClinicRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | Hormone-receptor-positive Breast CancerUnited States
-
Novartis PharmaceuticalsWithdrawn
-
Medical College of WisconsinWithdrawnAdvanced Breast Cancer | Solid TumorUnited States
-
Henan Cancer HospitalNot yet recruiting
-
Novartis PharmaceuticalsRecruitingMetastatic Breast CancerUnited States, Lebanon, Hong Kong, Turkey, Vietnam, Brazil, Italy, South Africa, Korea, Republic of, Poland, Taiwan, Singapore, Japan, Spain, Costa Rica, Greece, Portugal, Argentina, Mexico
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Recruiting
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruitingHR+/HER2- Advanced and/or Metastatic Breast Cancer
-
National Taiwan University HospitalUnknown
-
Henan Cancer HospitalNot yet recruitingAdvanced Breast Cancer | Treatment | HR Low/HER2 Negative
-
Fudan UniversityNot yet recruitingNeoadjuvant Therapy | Early Breast Cancer | HR+HER2- Breast Cancer
-
Georgetown UniversityMedstar Health Research Institute; Breast Cancer Research Foundation; Georgetown-Howard...TerminatedBreast CancerUnited States
-
AstraZenecaParexelCompletedHealthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)Germany
-
Carrick Therapeutics LimitedPfizerRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerSpain, United States, Turkey, Hungary
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingBreast Neoplasms | Nipple DischargeChina
-
Children's Hospitals and Clinics of MinnesotaM.D. Anderson Cancer Center; Washington University School of Medicine; Dana-Farber... and other collaboratorsRecruitingNeuroblastoma | Thyroid Carcinoma | Pineoblastoma | Wilms Tumor | Embryonal Rhabdomyosarcoma | Ovarian Sarcoma | Sertoli-Leydig Cell Tumor | Pleuropulmonary Blastoma | Gynandroblastoma | DICER1 Syndrome | Cystic Nephroma | Renal Sarcoma | Nodular Hyperplasia of Thyroid | Nasal Chondromesenchymal Hamartoma | Ciliary Body... and other conditionsUnited States
-
RemeGen Co., Ltd.Recruiting
-
Institut Cancerologie de l'OuestCompletedNon Metastatic Breast CancerFrance
-
Technical University of LisbonCompleted
-
Bukwang PharmaceuticalCompletedHealthy Adult MaleKorea, Republic of
-
Dana-Farber Cancer InstituteNovartisTerminatedMetastatic Hormone-Receptor-Positive (HR+) Breast Cancer | HER2-Negative Breast Cancer | Metastatic Epithelial Ovarian CancerUnited States